Vivek Mittal, PhD

Vivek leads Health Advances’ San Francisco office and is focused on building Health Advances’ expertise in translational medicine through his work across therapeutics, diagnostics, and life science tools.

This broad exposure allows Vivek to leverage his scientific background to help companies across the spectrum of discovery, development, and commercialization of novel technologies. A core component of Vivek’s work is in opportunity identification, either for new platform technologies or for companies seeking to expand into new markets. Experienced in multiple therapeutic areas, he has particular expertise in immunology, oncology, ophthalmology, and orphan disease.

Prior to his work at Health Advances, Vivek earned his PhD in Molecular Cell Biology at Washington University in Saint Louis, studying G-protein regulation. While at WashU, Vivek founded the BioEntrepreneurship Core (BEC), a program designed to introduce life science students to the drug development process. BEC was a awarded a Kauffman Grant and has gone on to train many like-minded students.

Vivek received a BA in Biochemistry/Molecular Biology and an MA in Biotechnology from Boston University.